LDN Petition to the European Parliament
We petition the European Parliament to make funds available for trials and research for LDN to achieve a licence and public availability.
We petition the European Parliament to make funding available, either directly through taxes or indirectly by directing research bodies to provide funding, to undergo trials for the generic drug, Low Dose Naltrexone (LDN). Primarily this is to be done for Cancer since there lies the biggest savings of life and economy, but then also for the many other diseases, such as MS, Crohns disease, Fibromyalgia, Rheumatoid Arthritis, and many more.
Alternatively, the drug should be made available on the basis of its widespread use and the widespread positive reports of the many doctors around the world who are currently using it. The evidence about this drug has overtaken the trials process already and as such, we ask also that this drug be made available as front line treatment, now. The research should then be performed to confirm the drug and resolve the many unanswered questions surrounding it. That a generic drug is proving so important in saving lives makes the unavailability carry a human rights burden too.
To summarise, we ask for the funding to be provided and the drug to be made freely available to those who request it. The drug has been proven safe at high dose usage with no toxicity issues so the safety trials are done, and we know of no drugs which become unsafe at low dose when safe at high ones. In 30 years, the drug industry has ignored this drug due to lack of return on investment, so we believe that only government led intervention can break this scandalous apathy. LDNNow, save our sick, save our economy.
Please note, we do NOT require any funding. All we want is your signature and support. After signing andsupporting this petition a page will pop up requesting donations, this will NOT be going to LDNNow. Your name and email address is all that is required. Thank you.
We have created a petition to urge the European Parliament to take the necessary steps to trial this drug and achieve the licences necessary to make this drug available to all.
Because of the lack of interest by the normal bodies who conduct trials - the drug companies - without political intervention, we will probably never see this general drug trialled. Therefore we need your help in this matter to overcome the apathy which is standing in the way. Thank you.
For more information please visit www.ldnnow.com